Bayer nears end game in merger talks with Monsanto

Bayer MonsantoMerger

German pharmaceutical and crops manufacturer Bayer AG (BAYGn.DE) said on [September 5, 2016] that its negotiations with Monsanto Co (MON.N) had advanced, and it was now willing to offer more than $65 billion to acquire the world’s largest seed company.

Bayer in a statement said that it was prepared to offer $127.50 per share in connection with a negotiated deal, up from its previous offer of $125 per share.

ChemChina agreed earlier this year to buy Switzerland’s Syngenta (SYNN.S) for $43 billion, after the latter rejected takeover approaches from Monsanto. Dow Chemical Co (DOW.N) and DuPont (DD.N) are forging a $130 billion merger, which is to be followed by a break-up into three businesses.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: Bayer sweetens Monsanto bid as talks enter final stretch

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...
Untitled

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend